Status:
UNKNOWN
Telemedical Devices in the Management of Type 2 Diabetes Mellitus to Improve Diabetic Control and Quality of Life
Lead Sponsor:
Centro Studi Internazionali, Italy
Collaborating Sponsors:
GPI SpA
Conditions:
Diabetes Mellitus, Type 2
Eligibility:
All Genders
18+ years
Brief Summary
The aim of this study is to understand, in adult patients with Type 2 diabetes mellitus, if the use of telemedicine (monitoring and treatment without patients having to attend a healthcare facility) a...
Detailed Description
Background and study aims Diabetes mellitus is a long-lasting disease in which the level of blood sugar is higher than normal. High level of sugar in the blood can lead to serious consequences, includ...
Eligibility Criteria
Inclusion
- Patients with type 2 diabetes mellitus (T2DM)
- Diagnosis of DM made at least 1 year before the start of the study
- Hypoglycemic treatment remained the same in the 3 months preceding the start of the study
Exclusion
- Diabetes other than T2DM
- Pregnant women
- Chronic conditions other than T2DM
- Unable to give informed consent
- Dementia or psychiatric conditions that can affect a person's will or ability to participate in the study
Key Trial Info
Start Date :
March 1 2018
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
July 31 2020
Estimated Enrollment :
350 Patients enrolled
Trial Details
Trial ID
NCT04038528
Start Date
March 1 2018
End Date
July 31 2020
Last Update
July 31 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
ASP Catanzaro
Catanzaro, Italy, 88100